Literature DB >> 8104752

Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection.

W V La Via1, S W Grant, H R Stutman, M I Marks.   

Abstract

To update the clinical profile of pediatric patients hospitalized with RSV infection, we retrospectively reviewed the records of 246 children (male:female ratio 1.44:1) admitted during one season to a tertiary-care hospital. The most common admitting diagnoses were bronchiolitis (37.4%), pneumonia (32.5%), and possible septicemia (13%). Median age was 3 months; median length of stay, three days. Twice as many minorities were admitted with RSV infection as all other admissions during the same year. Family history of asthma, while common (35%), did not affect length of stay or complications. Of the 38 (15%) patients requiring intensive care, 29 (76%) underwent ventilation. Patients with underlying cardiopulmonary disease had more complications, were more likely to require intensive care (about 50%), and had significantly longer hospital stays than others. All three patients (1.2%) who died had congenital heart disease. Common risk factors included young age, chronic cardiopulmonary disease, male sex, and possibly family history of asthma. Although the most typical clinical diagnoses remain bronchiolitis and pneumonia, a systemic illness resembling the sepsis syndrome has emerged at our institution as a significant clinical presentation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104752     DOI: 10.1177/000992289303200801

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  8 in total

1.  Local variability in respiratory syncytial virus disease severity.

Authors:  A H Brandenburg; P Y Jeannet; H A Steensel-Moll; A Ott; P H Rothbarth; W Wunderli; S Suter; H J Neijens; A D Osterhaus; C A Siegrist
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

2.  Relationship between clinical severity of respiratory syncytial virus infection and subtype.

Authors:  M C Kneyber; A H Brandenburg; P H Rothbarth; R de Groot; A Ott; H A van Steensel-Moll
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

3.  RFI-641, a potent respiratory syncytial virus inhibitor.

Authors:  Clayton C Huntley; William J Weiss; Anna Gazumyan; Aron Buklan; Boris Feld; William Hu; Thomas R Jones; Timothy Murphy; Antonia A Nikitenko; Bryan O'Hara; Gregory Prince; Susan Quartuccio; Yuri E Raifeld; Philip Wyde; John F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 4.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  The clinical picture presented by premature neonates infected with the respiratory syncytial virus.

Authors:  J Forster; R F Schumacher
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

6.  Influenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methods.

Authors:  Mark G Thompson; Danielle R Hunt; Ali K Arbaji; Artan Simaku; Veronica L Tallo; Holly M Biggs; Carolyn Kulb; Aubree Gordon; Ilham Abu Khader; Silvia Bino; Marilla G Lucero; Eduardo Azziz-Baumgartner; Pat Shifflett; Felix Sanchez; Basima I Marar; Ilirjana Bakalli; Eric A F Simões; Min Z Levine; Jennifer K Meece; Angel Balmaseda; Tareq M Al-Sanouri; Majlinda Dhimolea; Joanne N de Jesus; Natalie J Thornburg; Susan I Gerber; Lionel Gresh
Journal:  BMC Infect Dis       Date:  2017-03-22       Impact factor: 3.090

7.  AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats.

Authors:  Akihito Sawada; Katsuhiro Komase; Tetsuo Nakayama
Journal:  Vaccine       Date:  2010-12-24       Impact factor: 3.641

8.  Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015.

Authors:  Martin T Jepsen; Ramona Trebbien; Hanne Dorthe Emborg; Tyra G Krause; Kristian Schønning; Marianne Voldstedlund; Jens Nielsen; Thea K Fischer
Journal:  Euro Surveill       Date:  2018-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.